- Kaiser Permanente names SVP, Fresno service area manager
- Nebraska hospital CEO resigns amid allegations of $38K in improper spending
- Northwell’s direct contracting business wants to ‘link up’ with other health systems
- PDS Health among 1st to deploy Epic-integrated AI platform
- CommonSpirit’s 5 targets for judging payer prior auth reform — and its Humana milestone
- LifeBridge names division president
- Private equity struggles in healthcare amid mounting pressures: 5 notes for dentistry
- Who’s actually winning the fight for ASC ownership?
- Why some ASCs are buying their own anesthesia groups
- Hospital Sisters Health System names chief technology officer
- Top Medicare Advantage plans for member satisfaction in 2026: JD Power
- How a 12-hospital system saved millions with an inventory overhaul
- Corporate medicine is burning out 90% of employed physicians: 10 survey findings
- HCA Florida hospital names assistant CFO
- GE HealthCare taps new CFO
- 6-property outpatient portfolio acquired
- Patients deserve every evidence-based option for mental healthcare
- 10 anesthesia controversies in 2026
- The $314K cost of employing a physician
- Who’s driving physician M&A in 2026? 5 deals to know
- 5 ways insurers are undercutting anesthesia payments: ASA
- Prior GLP-1 use doesn’t affect bariatric surgery results: 6 things to know
- Statement on Regulation Crypto Assets: Fit-for-purpose Exemptions for Crypto Market Innovation
- Filling the Regulatory Tank: Regulation Crypto Assets Proposing Release
- Statement on Regulation Crypto Assets
- Dental therapy program enrollment up 533% in 5 years
- Dental assisting program enrollment down 5.2% in 5 years
- Dental hygiene program enrollment up 15% in 5 years
- Surgery Partners ditches its $200M M&A target in favor of de novo growth: 5 things to know
- The dental specialties DSOs will prioritize next
- Statement on Commencement of Appointment Process for Public Company Accounting Oversight Board Seat
- Dental school enrollment in the 10 states with the most dental shortage areas
- How To Protect Yourself During Wildfire Season
- Ballmer Institute lands $125M to expand child behavioral health training nationwide
- Judge weighs whether man charged with killing dentist can act as own attorney
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
- Included Health to offer Carrum specialty care for alternative plan members
- 52 behavioral health executive moves to know
- Hospital performance improves in June, but lags 2025
- University of Toledo gets nearly $2M to support behavioral health workforce
- CTA reporting requirements eliminated for most dental practices: 5 things to know
- National Alliance on Mental Illness names chief medical officer
- Pennsylvania opens 24/7 behavioral health crisis center
- Cyber criminals target DSOs, dental groups: 3 updates
- OpenAI boosts mental health safeguards for teens
- UnitedHealthcare expands behavioral coaching to 13 million members
- Kindergarten Vaccine Exemptions Hit Record High, New CDC Data Shows
- Loneliness Is A Health Crisis, But Doctors Alone Can't Cure It, Analysis Argues
- Ousted OHSU Healthcare CEO files lawsuit alleging wrongful termination, discrimination
- JD Power: Member satisfaction with Medicare Advantage plans continues to slide
- AMA applauds updated CMS prior authorization reporting guidance
- Constipation In Space: A New Study Provides Answers
- Social Media Beauty Trends May Up Teens' Exposure To Hormone-Disrupting Chemicals
- HIPAA-compliant marketing platform Ours Privacy lands $15M amid growing pixel concerns
- Pharma commercialization partner Valeris brings in new strategy chief
- Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS’ global test
- CSL shares up 17% as immunoglobulin boost points to signs of recovery
- R1 acquiring Humata Health to bolster AI-powered prior authorizations
- Revance hires Janelle Wichmann as chief marketing officer of skincare unit
- CMI adopts orphan drug field with dedicated center of excellence
- Waist Size Is Accurate Way To Gauge Unhealthy Excess Weight, Study Says
- Panel Offers First Guidelines For Using E-Cigarettes To Help Smokers Quit
- Celcuity keeps cool amid questions about Revtorpyk launch timing
- Newsom Promotes Affordable Insulin, But California's Generic Label Off To A Slow Start
- What Geriatric Emergency Departments Do Differently
- Drive for Nuclear Power Boosts Uranium Industry — And Tribal Health Concerns in Southwest
- Rural primary care company Hopscotch clinches $53M to expand beyond NC
- Eurofins expands operations to meet growing high-potency API demand
- 24 new behavioral health projects to know
- Four health systems, including Ochsner and Denver Health, go live with Epic's real-time prior authorization checks
- 8 new psychiatric residency programs to know
- DocGo agrees to acquire virtual care provider Hicuity Health, assumes $52M debt
- Papa, eternalHealth expand partnership around Plus platform
- Happy Health secures $75M to expand AI-powered care in the home starting with sleep apnea
- As healthcare costs weigh on patients, states could play a bigger role, report finds
- Jalapeño Recalls Keep Growing As Salmonella Outbreak Investigation Continues
- Music Streaming Linked To Rise In Traffic Deaths
- EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu
- Quanovate takes back marketing claims for Mira fertility wand after P&G challenge
- Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
- Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup
- Quartz Countertop Workers Are Falling Prey To Lung Disease
- Kaiser Permanente notches 4.6% Q2 operating margin, $5.3B net income
- Epic faces Federal Trade Commission antitrust investigation, Reuters reports
- Innovaccer, Mastek ink strategic partnership to scale agentic AI in healthcare globally
- Sandoz strikes $322M biosimilars deal with Shanghai Henlius
- Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication
- Many Smokers Unaware Of Heart, Brain Risks Of Smoking
- Tylenol, Other Medications Fuel Spike In Liver Damage Cases, Poison Center Data Says
- AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
- My Husband Was Kicked Out Of Hospice For Dying Too Slowly
- Tadalafil (Cialis), Used for BPH and ED, Might Increase Glaucoma Risk, Study Says
- Kennedy’s Quiet Hunt for Autism Culprits Stalls as Trump Orders Baseless Changes to Childhood Shots
- Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start
- Inside agency view: Real Chemistry’s Frank Mazzola on audience nuance and rewarding creativity
- Abridge expands AI decision support to more clinicians in bid to become healthcare's copilot
- Danish politicians call out Eli Lilly obesity campaign
- Universal Health Services closes $835M Talkspace acquisition
- Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order
- States Enact Emergency Orders On Kratom While Awaiting Federal Rules
- Study examines how ICHRA adoption could help stabilize ACA risk pools
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Screen Time Is Not All Bad For Kids' Brains
- Processed Foods Linked To Prostate Cancer Risk
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Industry Voices—AI should help cancer patients survive the healthcare system
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- How consumerization is reshaping pharma marketing
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- FDA Wants More Information From Food Makers On New Food Chemicals
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Beyond Compliance: Rethinking No Surprises Act strategy
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
Michigan healthcare freedom community forum
Dr. Joseph Varon, M.D. is a prominent critical care physician Houston, Texas. He has made significant contributions to the field of medicine, particularly during the COVID-19 pandemic. His current positions are:
- Chief of Staff at United Memorial Medical Center
- Chairman of the Board at United General Hospital
- President of the Independent Medical Alliance
- Professor of Acute and Continuing Care at the University of Texas Health Science Center in Houston
- Clinical Professor of Medicine at the University of Texas Medical Branch in Galveston
Dr. Varon takes exception to the muzzling of physicians which began during the COVID pandemic as public health officers ruthlessly stifled all medical challenges to politically approved treatments:
https://brownstone.org/articles/what-covid-policy-did-to-doctors-who-refused-to-stay-silent/
What Covid Policy Did to Doctors Who Refused to Stay Silent
By Joseph Varon - March 14, 2026The sound I remember most from the early days of Covid-19 is not the alarms. It was the silence between them. Intensive care units became Covid wards. Monitors glowed in dark rooms while ventilators pushed air into failing lungs. Nurses, shrouded in protective gear, moved quietly. Families were absent—barred from being with loved ones in their final hours.
One night at 3 am, I stood by a patient whose oxygen levels were steadily falling. Outside the room, another patient crashed. Down the hall, a third awaited intubation. For months, this was every night. For 715 consecutive days, I worked in that environment without taking a single day off. In moments like that, medicine becomes very simple. There are no politics in an ICU at 3 am. There is only a physician and a patient, and the responsibility to do everything possible to keep that patient alive.
That philosophy has guided physicians for generations. It is the foundation of clinical medicine: when a patient is dying, you explore every reasonable option that might help.
Yet during Covid, something extraordinary happened. What made the shift so jarring was not simply the presence of disagreement. Physicians have always disagreed. In fact, disagreement is the normal language of medicine. Grand rounds exist for that reason. Journal clubs exist for that reason. The entire structure of scientific publication—from peer review to replication—exists because medicine advances through argument, not obedience. During the pandemic, however, the culture of medicine changed almost overnight. Instead of asking whether a treatment might work, institutions began asking whether discussing that treatment might create the wrong public message. The priority quietly shifted from discovery to control.
Scientific debate faded. Physicians who questioned policies or explored treatments were treated as threats rather than colleagues. Instead of debate, there was enforcement.
Hospitals warned physicians to stay quiet. Medical boards hinted at disciplinary action. Social media platforms censored discussion of therapies that doctors around the world were actively studying. Media outlets portrayed dissenting physicians as reckless or dangerous. What had once been normal scientific discourse was suddenly labeled misinformation.
To physicians trained in earlier decades, this shift was deeply unsettling. Medicine has always lived with uncertainty. Treatments begin as hypotheses and evolve through observation and debate. During the AIDS crisis, clinicians tried multiple strategies before effective therapies emerged. The same was true for sepsis, trauma care, and organ transplantation. No one expected immediate unanimity. Yet during Covid, uncertainty itself became suspect. If a physician acknowledged that evidence was incomplete—or that clinical experience suggested alternative approaches—those statements were sometimes interpreted as challenges to authority rather than contributions to knowledge.
For those of us working inside the ICU, the shift was startling. Medicine had always thrived on disagreement. Physicians argued over treatment strategies, debated emerging evidence, and learned from one another’s experiences. The process was messy, sometimes loud, and occasionally uncomfortable—but it was also the engine of medical progress. During Covid, that process was replaced by something else entirely: the expectation of unanimity. I experienced this transformation firsthand.
During the pandemic, I spoke publicly about what I was seeing inside the ICU—what treatments appeared to help, what policies seemed ineffective, and why physicians needed the freedom to treat patients according to their clinical judgment.
Those comments triggered a reaction that made clear how medical freedom—a core value of our profession—had come under threat. Professional attacks followed, and colleagues were pressured to distance themselves. Invitations disappeared. Media narratives were constructed that bore little resemblance to the reality many of us were witnessing inside hospitals. But perhaps the most revealing response was silence.
Privately, many physicians admitted that the environment had become toxic for honest scientific discussion. In quiet conversations they would agree that open debate had been replaced by institutional pressure. Publicly, however, very few were willing to risk speaking. I chose not to remain silent.
That silence did not necessarily mean physicians agreed with what was happening. More often it meant they understood the risks of speaking. Hospitals depend on reputations. Universities depend on funding. Physicians depend on licenses. When the boundaries of acceptable opinion begin to narrow, most professionals instinctively step back. It is not cowardice; it is survival. But the cumulative effect of that silence is profound. When enough physicians remain quiet, the illusion of consensus begins to replace the reality of debate.
Over the course of the pandemic, I gave more than 4,000 television and media interviews, attempting to explain what physicians were seeing on the front lines and defending the principle that doctors must be allowed to think, question, and treat patients according to their best clinical judgment. The experience was both exhausting and illuminating. Again and again, I found myself explaining basic principles of medicine to audiences who had been told that questioning official policy was somehow dangerous.
Medicine has never advanced through silence. Every major breakthrough in medical history, from antibiotics to organ transplantation, began with physicians willing to challenge prevailing assumptions. Scientific progress depends on disagreement. It requires physicians to ask uncomfortable questions and explore possibilities that established authorities may initially reject. When debate is replaced by enforced consensus, science ceases to function.
That decision to speak carried consequences. Professionally and financially, the cost was substantial. The controversy surrounding Covid treatment debates resulted in lost opportunities, canceled collaborations, and significant professional retaliation. The economic impact was severe, resulting in roughly a 60 percent reduction in my income, a consequence that continues to this day.
Financial pressure has always been one of the most effective tools for enforcing conformity in any profession. Medicine is no exception. Physicians spend decades training, accumulate significant professional responsibilities, and depend on institutional relationships to practice. When controversy threatens those relationships, the safest option is often to say nothing. Many doctors understood this reality during Covid. Some quietly expressed agreement in private conversations but made clear they could not say so publicly. In that environment, silence became the profession’s default posture. For many physicians, that kind of pressure is enough to ensure silence. But the financial cost was never the hardest part.
What made the experience even more disturbing was watching what happened to colleagues who chose to speak openly. Some physicians lost hospital privileges almost overnight. Others faced medical board investigations triggered not by patient complaints, but by their public statements or willingness to question prevailing policies. Careers built over decades were suddenly placed under threat. A number of doctors saw research collaborations vanish, academic appointments quietly withdrawn, and professional reputations publicly attacked. The message became unmistakable: disagreement would carry consequences.
The personal toll was often even greater. Financial pressure, professional isolation, and relentless public scrutiny spilled into physicians’ private lives. I watched colleagues struggle as marriages fractured under the strain of media attacks, legal battles, and the sudden collapse of careers they had spent their lives building. Some left clinical practice entirely. Others retreated from public discussion simply to protect their families. The pandemic revealed something few physicians had previously experienced—the realization that speaking honestly about patient care could place not only one’s career at risk, but one’s personal life as well.
The hardest part was watching medicine surrender one of its most essential principles: the freedom to think and speak for patients. The pandemic response exposed how vulnerable modern medicine has become to political pressure, institutional fear, and media narratives. Decisions that should have remained within the realm of clinical judgment were increasingly dictated by bureaucratic authority.
In theory, medicine is guided by science. In practice, during Covid, it often appeared to be guided by messaging. That realization has prompted an important effort to document what happened during the pandemic and to ensure that physicians’ experiences are not erased from the historical record. One such effort is the COVID Justice initiative, which seeks to collect and document the stories of doctors, nurses, scientists, and patients affected by pandemic policies. The COVID Justice Resolution is an attempt to ensure that the suppression of scientific debate, the censorship of physicians, and the professional retaliation many experienced are openly acknowledged rather than quietly forgotten. The goal is not vengeance. It is accountability and transparency.
If the medical profession refuses to confront what happened during the pandemic—if it pretends that physicians were not pressured, censored, or punished—then the same mistakes will almost certainly be repeated during the next public health crisis.
History shows that institutions rarely correct themselves without accountability. On the front lines, many of us witnessed something deeply troubling: modern medicine’s increasing dependence on bureaucratic authority. When that authority collides with bedside care, physicians can find themselves forced to choose between professional safety and patient advocacy. Every doctor eventually faces that choice. During Covid, many of us faced it together. Some chose silence. Others chose to speak.
Speaking came with consequences. It costs reputations, careers, and, in many cases, substantial income. But the alternative—remaining silent while scientific debate was suppressed and physicians were discouraged from thinking independently—would have been a far greater betrayal of the profession.
Medicine cannot survive if doctors fear speaking freely and challenging consensus on behalf of their patients.
The next public health crisis will come. That is inevitable. When it does, the profession must remember what happened during Covid: how easily fear can replace reason, how quickly debate can be labeled dangerous, and how fragile scientific freedom becomes when institutions decide that certain questions are no longer allowed.
The real lesson of the pandemic is not about a virus. It is about the courage required to defend the integrity of medicine itself. Physicians must remain free to question, to debate, and to innovate in the service of their patients. Without that freedom, medicine becomes little more than bureaucratic compliance dressed in a white coat. And patients deserve far better than that. Because when physicians lose the freedom to question, patients lose something far more precious: the possibility that someone, somewhere, will be willing to challenge the rules in order to save their life.
That is the real price of speaking. The only question now is whether the medical profession still has the courage to pay it.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























